Cambridge Therapeutic Technologies
Teaneck, US · Delaware LLC
Biotech
Founders & leadership
JK
John KleinExecutive
BA
Barry A. PosnerExecutive
JD
Joseph DosSantosExecutive
Board
MW
Marc WassermanBoard director
Reported raises · per SEC filings
Form D private placements$6M disclosed across 1 round · 2016
▶$6MraisedOct 2016 · 14 investors · PharmaceuticalsRule 506(b)
▶$6MraisedOct 2016 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John KleinExecutive Officer, Director
- Marc WassermanDirector
- Barry A. PosnerExecutive Officer, Director
- Joseph DosSantosExecutive Officer
- Offering amount
- $7M
- Amount sold
- $6M
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cambridge Therapeutic Technologies raised?
- Cambridge Therapeutic Technologies has disclosed $6M raised across 1 round.
- Where is Cambridge Therapeutic Technologies headquartered?
- Cambridge Therapeutic Technologies is headquartered in Teaneck, US.